Home > Insider Trading > Filing (0001209191-22-006757)

Filing Details

Accession Number:: 0001209191-22-006757
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-03 16:06:58
Reporting Period:: 2022-02-01

Accepted Time:: 2022-02-03 16:06:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Global Research And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-01	8,166	$0.00	41,755	No	4	A	Direct
Common Stock	Acquisiton	2022-02-01	11,628	$0.00	53,383	No	4	A	Direct
Common Stock	Acquisiton	2022-02-01	12,314	$0.00	65,697	No	4	A	Direct
Common Stock	Acquisiton	2022-02-02	4,660	$86.52	70,357	No	4	M	Direct
Common Stock	Disposition	2022-02-02	500	$247.73	69,857	No	4	S	Direct
Common Stock	Disposition	2022-02-02	127	$248.65	69,730	No	4	S	Direct
Common Stock	Disposition	2022-02-02	754	$249.97	68,976	No	4	S	Direct
Common Stock	Disposition	2022-02-02	980	$251.22	67,996	No	4	S	Direct
Common Stock	Disposition	2022-02-02	900	$252.10	67,096	No	4	S	Direct
Common Stock	Disposition	2022-02-02	1,099	$253.41	65,997	No	4	S	Direct
Common Stock	Disposition	2022-02-02	300	$254.46	65,697	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-02-02	4,660	$86.52	4,660	$86.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-02-02	No	4	M	Direct

Footnotes

Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022.
Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022.
Restricted stock unit award that vests in installments beginning on 02/24/2023.
Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $247.73 (range $247.35 to $248.34).
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $248.65 (range $248.46 to $249.34).
Open market sales reported on this line occurred at a weighted average price of $249.97 (range $249.61 to $250.33).
Open market sales reported on this line occurred at a weighted average price of $251.22 (range $250.71 to $251.70).
Open market sales reported on this line occurred at a weighted average price of $252.10 (range $251.75 to $252.72).
Open market sales reported on this line occurred at a weighted average price of $253.41 (range $253.05 to $253.99).
Open market sales reported on this line occurred at a weighted average price of $254.46 (range $254.34 to $254.58).
Fully vested.